{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Nam-Kyung Yu"}, {"accession": "MS:1000589", "name": "contact email", "value": "namkyung@scripps.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Scripps Research"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Lilia Iakoucheva"}, {"accession": "MS:1000589", "name": "contact email", "value": "lilyak@health.ucsd.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "UCSD"}]}], "description": "The 16p11.2 is the most common copy number variant (CNV) associated with Autism Spectrum Disorder (ASD). We used patient-derived cerebral organoids to investigate neurodevelopmental pathways dysregulated by dosage changes of 16p11.2 CNV. To investigate molecular dysregulation in DEL and DUP organoids, we carried out RNA sequencing and Tandem Mass Tag mass spectrometry (TMT-MS) on 1-month and 3-month organoids from the same samples. In proteomic analyses, we quantified a total of 6126 proteins in 1-month and 5481 proteins in 3-month organoids, with 13 and 11 proteins from within 16p11.2 CNV, respectively. Transcriptomic and proteomic profiling of organoids identifies the key drivers of functional effect by 16p11.2 CNV during neocortical development. ", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=842031454fb24abdb11decceaa4fd052"}, {"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000084727/"}], "identifiers": [{"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000084727"}, {"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD016855"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}], "instruments": [{"accession": "MS:1002416", "name": "Orbitrap Fusion"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "TMT 10-plex"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "cerebral organoid"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "autism"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "16p11.2 CNV"}], "modifications": [{"accession": "MOD:01060", "name": "S-carboxamidomethyl-L-cysteine"}, {"accession": "MS:1001460", "name": "unknown modification"}], "publications": [{"terms": [{"accession": "MS:1002853", "name": "Dataset with no associated published manuscript"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "human"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Cerebral organoids model neocortical development disrupted by 16p11.2 CNV in autism"}